An exclusive technique of Ingenes

What is IVF MORE®?

We restore your eggs. We don't replace them.

IVF MORE® is an Instituto Ingenes technique that restores the quality of your own eggs, so you can pursue pregnancy with your own genetic material instead of turning to egg donation.

Illustration of a human egg being restored: the cytoplasm lights up from within while the nucleus stays untouched

IVF MORE® (Magnetic Ovulatory Restoration) is an advanced fertility treatment that restores poor-quality eggs, particularly in women of advanced age or with endometriosis, polycystic ovary syndrome (PCOS) or repeated implantation failure.

Unlike egg donation, IVF MORE® works with your own eggs.

It improves their capacity to divide and be fertilised without altering your genetic material: a patented scientific approach that restores the egg's function while your DNA stays untouched.

Why egg quality declines

With age, or in the presence of certain conditions, eggs show:

  • An energy deficit. Less ATP, which prevents proper cell division.1
  • Oxidative stress that damages DNA and mitochondria.2
  • A disorganised cytoskeleton, the structure that guides genetic division.
  • Genetic errors that lead to abnormal embryos or implantation failure.3
Illustration of a mature egg in optimal condition: homogeneous, translucent cytoplasm, an even zona pellucida and an intact polar body

Healthy egg

Illustration of a poor-quality egg: dark, granular cytoplasm with vacuoles and a thickened, irregular zona pellucida

Poor-quality egg

Illustrations. A healthy egg has homogeneous, translucent cytoplasm and an even zona pellucida. A poor-quality one turns granular, accumulates vacuoles and hardens its shell, which is what restoration sets out to reverse.

Together these raise the risk of early miscarriage and make pregnancy harder to achieve. It is a question of quality, not only of quantity: a woman is born with up to two million eggs, retains around 5% of that reserve by 30 and close to 1% by 40, and many of the remaining ones carry metabolic and structural changes.

As age advances, oocytes turn darker, more granular and harder in their shell (zona pellucida), and fertilisation and good embryo development get progressively harder to achieve.

Egg quality Age (years) 20 25 30 35 ≥40 Hardened Granular +Genetic errors
Micrographs from the Ingenes laboratory, ordered by maternal age. After 44, fewer than 1% of eggs produce a chromosomally normal embryo.

Age and fertility: why this matters now

Over the past decades, women’s reproductive profiles have changed radically. More and more women choose to postpone motherhood for social, professional and personal reasons:

  • Wider access to education and to professional careers.
  • Seeking economic and emotional stability before starting a family.
  • Shifts in traditional family models and in gender roles.
  • Advances in reproductive technology that widen the fertility window.

Across Latin America, Europe and Asia, the average age at first pregnancy has moved from 25 to over 30 in just two generations. Reproductive biology has not kept pace: female fertility still depends on ovarian age.13

What that costs in fertility

  • 1 in 6couples face difficulty conceiving
  • +50%of female infertility is tied directly to ovarian ageing
  • +75%of eggs may carry chromosomal abnormalities at 40
  • <5%chance of natural pregnancy per cycle at that age

Without medical intervention, time becomes fertility’s greatest enemy.

A problem that is already demographic

Postponing motherhood does not only affect individuals. The demographic consequences are visible across much of the world, with birth rates below population replacement level:

  • According to the World Health Organization, 1 in 6 people worldwide face fertility problems.14
  • In countries such as Italy, South Korea and Japan, birth rates are among the lowest on the planet, threatening the sustainability of economic and social systems.
  • In Latin America, fertility rates have fallen by more than 50% since 1960.

This scenario demands innovative medical solutions to preserve and restore fertility in women who, for many reasons, cannot conceive earlier in life.

The answer to the new reproductive reality

IVF MORE® is a direct response to that challenge. It is not one more fertility treatment: it is an advanced egg restoration technique that improves egg quality without altering its genetic load. Unlike egg donation, it preserves the patient’s genetic identity even when her eggs show low metabolic or structural capacity.

Thanks to this technology in development:

  • Women of advanced age can access restored eggs with greater potential for fertilisation, embryo development and pregnancy.
  • The need to turn to egg donation is reduced, particularly where viable eggs are still available.
  • The outlook improves in complex diagnoses such as endometriosis, polycystic ovary syndrome or repeated implantation failure.
  • The effects of ovarian ageing, one of the main barriers in contemporary female fertility, are mitigated.

What an egg needs to make a viable embryo

To form a healthy embryo, an egg has to meet three conditions at once: enough cellular energy to divide, an intact cytoskeleton to organise its chromosomes, and the right genetic signalling to direct its own development. In aged eggs, anaerobic pathways take over, producing energy inefficiently and accumulating toxic waste.1

The distinction that defines the technique sits inside the cell:

Micrograph of a poor-quality egg, dark and granular

Poor oocyte quality

IVF MORE®
Micrograph of a restored egg with clear, homogeneous cytoplasm

Restored egg

Micrograph of an unrestored egg with vacuoles

Egg left unrestored

Micrograph of a viable blastocyst

Blastocyst viable for transfer

Micrograph of a non-viable blastocyst

Non-viable blastocyst or arrested embryo

Micrographs from the Ingenes laboratory. From the same starting point, restoration opens a branch that reaches a transferable blastocyst; without it, development stops.

Diagram

Under the microscope

Micrograph of a human egg, with the nucleus circled and the cytoplasm outlined, annotated in the Ingenes laboratory
  • Nucleus

    Holds your genetic material: the chromosomes you pass on. IVF MORE® never touches it. The embryo is genetically yours.

  • Cytoplasm

    The rest of the cell: mitochondria, energy factors and the machinery that lets the egg divide. This is what ages, and this is what the technique restores.

Your genetic information stays in the nucleus. What we restore is the cytoplasm around it.
Diagram of the phases of cell division (interphase, prophase, metaphase, anaphase and telophase), with the nucleus, centrioles, mitotic spindle and chromosomes labelled in each
The phases of cell division, labelled in Spanish: interfase, profase, metafase, anafase and telofase. The egg has to get through all of them with enough energy and an intact cytoskeleton; fail at any one and the chromosomes are shared out wrong.

How IVF MORE® works

The treatment runs in tightly controlled laboratory phases:

  1. 01

    Oocyte metabolic diagnosis

    Eggs are retrieved and assessed for energy competence and mitochondrial function. Mitochondria, the cell's power plants, supply the ATP and NADPH that indicate whether an egg can generate the energy it needs.

  2. 02

    Cytoplasmic restoration

    Metabolic and mitochondrial factors are infused using equipment built for this technique, which optimises mitochondrial function, improves energy production and lowers oxidative stress.4 If the egg's own cytoplasm is not suitable, cytoplasm from a compatible donor egg may be used, again without altering the patient's nuclear DNA.

  3. 03

    Fertilisation and optimised culture

    Restored eggs are fertilised with the best sperm, selected through techniques such as PICSI or ICSI, and cultured under controlled conditions.

  4. 04

    Culture in magnetic fields

    The cytoskeleton has to be organised for cell division to be accurate. In aged or poor-quality eggs it is weakened. Magnetic fields are used to support that structure during culture.5

The technique is Dr. Shoukhrat Mitalipov’s, of the Center for Embryonic Cell and Gene Therapy in Oregon, a world leader in mitochondrial biology.6 He travelled to Mexico City to train the Ingenes embryology team himself, and they are the ones who carry out each treatment.

Egg retrieval for IVF MORE® has to take place in the specialised Ingenes laboratory in Mexico City.

Dr. Shoukhrat Mitalipov with the medical and embryology team at Instituto Ingenes in the laboratory
The Instituto Ingenes embryology team in the Mexico City laboratory, where retrieval and restoration take place.

How it helps prevent genetic errors

Two structures decide whether chromosomes are distributed correctly. The cytoskeleton is the egg’s internal scaffold. The meiotic spindle forms from it and aligns the chromosomes at fertilisation.

When an egg is of poor quality, the cytoskeleton loses its organisation, the spindle becomes unstable, and division comes out unbalanced. The consequence is errors in chromosomal distribution: trisomies such as Down syndrome, monosomies such as Turner syndrome, or embryos that are not viable.3

Poor-quality egg

The cytoskeleton loses its organisation, the spindle destabilises and the chromosomes fail to align.

Restored egg

The cytoskeleton reorganises, the spindle stabilises and the chromosomes divide evenly.

Diagram. Chromosomes (in blue-grey) must line up on the equator before they are pulled to the two poles. When the spindle is unstable, that split comes out uneven, which is where trisomies, monosomies and non-viable embryos come from.

By restoring the cytoplasm with energy factors, growth factors and functional mitochondria, IVF MORE® acts on the root of the problem rather than its consequence: the cytoskeleton reorganises, the spindle stabilises, and the cell recovers its ability to divide chromosomes accurately.

Characteristic Non-restored egg Restored egg with IVF MORE®
Cellular energy Low ATP production Energetic competence restored
Cytoskeleton Disorganised Reorganised and functional
Risk of genetic alteration High: trisomies, monosomies Significantly decreased
Cell division Deficient Optimal and stable
Implantation success Low pregnancy rate Increased pregnancy rate

Who can benefit from IVF MORE®?

IVF MORE® offers an alternative to egg donation, designed for women facing challenges related to egg quality due to:

  • Advanced age, where the egg accumulates meiotic errors.3
  • Endometriosis, which alters the oocyte’s transcriptomic profile and IVF outcomes.7,8,9,10
  • Polycystic Ovary Syndrome (PCOS) and embryo arrest.11,12
  • Repeated failed IVF attempts.
  • Embryos with chromosomal abnormalities detected with PGT-A.
  • Vitrified eggs whose quality you want to improve before fertilisation.

Even with a single mature egg, IVF MORE® can be applied.

  • Micrograph of an atretic oocyte with retracted, darkly granulated cytoplasm

    Atretic

  • Micrograph of an oocyte with granular cytoplasm

    Granular cytoplasm

  • Micrograph of an oocyte with vacuoles clustered in the cytoplasm

    Vacuolated cytoplasm

  • Micrograph of an oocyte that is oval rather than spherical

    Ovoid

  • Micrograph of an oocyte with several polar bodies in the perivitelline space

    Multiple polar bodies

  • Micrograph of an oocyte with a thickened zona pellucida

    Thick zona pellucida

  • Micrograph of an oocyte with the endoplasmic reticulum visible as a pale area

    Visible endoplasmic reticulum

  • Micrograph of an oocyte with a disproportionately large polar body

    Giant polar body

  • Micrograph of an oocyte with a septate zona pellucida

    Septate zona pellucida

Abnormal oocytes as they appear in the laboratory. Each of these (of the cytoplasm, the shape, the polar body or the shell) compromises the egg's ability to fertilise and divide.

Scientific evidence

  • Seal: 70% of restored embryos
  • Seal: reduction of genetic alterations
  • Seal: higher implantation rate
Micrograph of a poor-quality egg: dark, granular cytoplasm with vacuoles visible under the zona pellucida

Poor egg quality

Micrograph of a restored egg: clear, homogeneous cytoplasm with a defined polar body

Restored egg

Micrographs from the Ingenes laboratory. On the left, the dark, granular cytoplasm of a poor-quality egg, with vacuoles under the zona pellucida. On the right, a restored egg: homogeneous, translucent cytoplasm. These are different cells, photographed to show the contrast.

Studies with IVF MORE® have shown promising results in women of advanced age, with endometriosis or with PCOS:

  • more viable embryos than with non-restored eggs
  • 70%of restored embryos came out viable
  • 82 → 26%chromosomal abnormalities, close to young donor levels
  • 19+babies born with this technology

Patients over 40 who previously could not produce viable embryos have achieved pregnancy with their own eggs.

These results come from the technique’s own case series. The technique is under development, protected by patent, and the articles supporting these findings are in the process of publication in peer-reviewed journals.

Motherhood at an advanced age is no longer a promise for the future.

IVF MORE® is not only an advance in regenerative medicine: it answers, concretely, the demographic and social shifts of the modern world. Backed by leading researchers such as Dr. Shoukhrat Mitalipov, it sets out to restore the potential of eggs and give more women the chance to be mothers with their own genetic material.

What to know before deciding

IVF MORE® requires at least one mature egg. If none is produced, even with stimulation, the technique cannot be applied. Some patients who have stopped menstruating can still produce an egg with ovarian stimulation; if that is your case, IVF MORE® remains an option.

In some cases, even when eggs are available, they may not be viable or may not respond adequately to restoration. When that happens, egg donation may be the most effective alternative for achieving a pregnancy.

For patients facing extremely low ovarian response, there is a complementary option: Ovagen, designed to reactivate ovarian function through growth factors and cellular regeneration where egg production is minimal.

If you have questions about whether IVF MORE® is right for you, our medical team can evaluate your case and help you find the option that best fits your needs.

Scientific sources14
  1. Zhu Q., Li Y., Ma J., Ma H., Liang X. (2023). Potential factors result in diminished ovarian reserve: a comprehensive review. Journal of Ovarian Research.
  2. Wang L., et al. (2021). Oxidative stress in oocyte aging and female reproduction. Journal of Cellular Physiology.
  3. RIKEN Center for Biosystems Dynamics Research (2017). Large cytoplasm predisposes oocytes to meiotic errors. RIKEN CDB.
  4. Woods D.C., Tilly J.L. (2015). Autologous Germline Mitochondrial Energy Transfer (AUGMENT) in Human Assisted Reproduction. Seminars in Reproductive Medicine.
  5. Zablotskii V., et al. (2016). How a High-Gradient Magnetic Field Could Affect Cell Life. Scientific Reports (Nature).
  6. Oregon Health & Science University. Meet Shoukhrat Mitalipov, Ph.D., Center for Embryonic Cell and Gene Therapy. OHSU.
  7. Harb H.M., et al. (2013). The effect of endometriosis on in vitro fertilisation outcome: a systematic review and meta-analysis. BJOG.
  8. Latif S., Saridogan E. (2023). Endometriosis, Oocyte, and Embryo Quality. Journal of Clinical Medicine.
  9. Senapati S., et al. (2016). Impact of endometriosis on in vitro fertilization outcomes: an evaluation of the SART database. Fertility and Sterility.
  10. Ferrero H., et al. (2019). Single-cell RNA sequencing of oocytes from ovarian endometriosis patients reveals a differential transcriptomic profile. Human Reproduction.
  11. Wood J.R., et al. (2007). Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. The Journal of Clinical Endocrinology & Metabolism.
  12. Li J., et al. (2021). Molecular Features of Polycystic Ovary Syndrome Revealed by Transcriptome Analysis of Oocytes and Cumulus Cells. Frontiers in Cell and Developmental Biology.
  13. Society for Assisted Reproductive Technology (2022). Live births per intended egg retrieval, national summary report. SART CORS.
  14. World Health Organization (2023). 1 in 6 people globally affected by infertility. WHO.

Next steps

Take the first step toward your baby with IVF MORE®

Our team is ready to support you every step of the way.

Schedule